Peer-reviewedCC BYBMJ Paediatrics Open
OP–199 Vaccination practices and safety of measles–mumps–rubella vaccine in children with food allergy
- 1Haseki Training and Research Hospital, Pediatric Allergy and Clinical Immunology, İstanbul, Türkiye
Related
- Measles risk and measles-mumps-rubella vaccination timing in dermatology patients on immunosuppressive therapy
- Case Study on Formulating a Multidose Lyophilized Measles-Rubella (MR) Vaccine Candidate for Local Manufacturing in Africa: Lab-Scale Results and Lessons Learned for Future Technology Transfer.
- Small Quantity Lipid-Based Nutritional Supplementation and Measles Vaccination Coverage in Children Aged 6-23\,Months: A Pragmatic Cluster-Randomized Trial
- Acceptability and feasibility of measles vaccination, small-quantity lipid-based nutrient supplementation, and their co-delivery among children aged 6-23 months in northern Nigeria: a qualitative study
- Prevalence of second-dose measles vaccination utilization and associated factors among MCV1-vaccinated children aged 15–36 months in Tocha Woreda, Dawuro Zone, Southwest Ethiopia, 2025
BibTeX
@article{sarikavak2026op199,
title = {{OP–199 Vaccination practices and safety of measles–mumps–rubella vaccine in children with food allergy}},
author = {Sibel Kaplan Sarikavak},
journal = {BMJ Paediatrics Open},
year = {2026},
month = oct,
doi = {10.1136/bmjpo-2026-epa-unepsa.196},
url = {https://doi.org/10.1136/bmjpo-2026-epa-unepsa.196},
note = {CC BY},
}
RIS
TY - JOUR
TI - OP–199 Vaccination practices and safety of measles–mumps–rubella vaccine in children with food allergy
AU - Sibel Kaplan Sarikavak
PY - 2026
DA - 2026/10/01
JO - BMJ Paediatrics Open
DO - 10.1136/bmjpo-2026-epa-unepsa.196
UR - https://doi.org/10.1136/bmjpo-2026-epa-unepsa.196
SN - 2399-9772
ER -